Results for tag: "Retinoblastoma Drug"

The Retinoblastoma Drug market is a subset of the Pharmaceuticals industry, focused on the development and sale of drugs used to treat retinoblastoma, a rare form of eye cancer. These drugs are typically used to reduce the size of the tumor, slow its growth, and reduce the risk of metastasis. They may also be used to reduce the risk of recurrence. Commonly used drugs include chemotherapy, targeted therapy, and radiation therapy. In some cases, surgery may be used to remove the tumor. The Retinoblastoma Drug market is highly competitive, with many companies vying for market share. Some of the major players in the market include Novartis, Pfizer, Merck, and Roche. Other companies in the market include Bristol-Myers Squibb, AstraZeneca, and Eli Lilly. Show Less Read more